Nemaura Medical Inc

0.00 (+1.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.40M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.1 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$0.38
50-Day MA$0.63
200-Day MA$0.98
See more pivots

Nemaura Medical Inc Stock, NASDAQ:NMRD

57 West 57th Street, Manhattan, New York, New York 10019
United States of America
Phone: +1.646.416.8000
Number of Employees: 38


Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.